[Haibu Pharmaceutical] Pregab β★εalin oral solution has succes¥←α&sfully been selected in the tenth¥σ batch of national centraliεzed procurement!
Classification:
Company News
Recent Events
Release time:
2024-12-16
On December 13, 2024↕σ¥™, at the recently co"♦ncluded opening meeting δ§σof the tenth batch of nationalΩ♥ drug centralized procurement, th φe oral solution of prega♦ αbalin developed by Haibu Phaσ•≠rmaceutical was successfully selected←★✔↔!
01. Ruianxi® Pregabaliε£n Oral Solution
The pregabalin oral solution has b§♠πeen approved for multiple indicaγ→tions worldwide, including p★÷₩£ostherpetic neuralgia, fibromyalgia, →×neuropathic pain due to"✔ spinal cord injury, dia→§betic peripheral neurop∞Ω±athy, and as an adjunctive thβ÷©erapy for partial seizures in patie♥δ±nts aged one month and older. Both do©↕×mestic and international guid↔φelines consistently recommend pre•δgabalin as the first-line treatme★β nt for postherpetic neuralgia€"∑₹ (PHN) and fibromyalgia (FM)↔✘.
Our product is equipped with a÷₽∏ precise drug delivery devi≥¶ce, making dose adjustments more δⶮconvenient; at the same t>σ >ime, the oral solution form ✘®πis easier to swallow than solid formul±π₽ations, making it the first choice foαφr elderly patients and those with s≠ wallowing difficulties due to epile<σpsy, stroke, or postherpetic neuralgia.¥₽
02. Strength Creates Q↑"uality - The Significance of Ce∏♣≥ntralized Procurement is Majo≠±r
Ruianxi® Pregabalin Oral Solution has×≥ successfully been selected in∑±Ω the tenth batch of nationa★≥×≈l centralized procurement! T©•his is not only a high recoσ®gnition of Haibu Pharmaceutical's com↕©pliance qualifications and product ☆quality but also a great blessing for mα♠♣any patients. With tλ"≈he implementation of th →e centralized procurement policy, Ruia♦&§↑nxi® Pregabalin Oral Solution wil←∏l be available at more favΩ÷orable prices and broader coverage, ♠©benefiting more patients and effecφ≤∞tively reducing their medica$™Ωtion burden.
At the same time, Haibu←→γ• Pharmaceutical will take this succλ↓essful selection in the na©¥→tional centralized procurement a♠∏s an opportunity to continuously ↕®improve product quality and tec®₽hnological innovation capabi→€≥lities, launching more h₩±λigh-quality, efficient, and safe <pharmaceutical products, allowing m×₹ore patients to access affordable and •☆σ high-quality medicines, bri¶'≈nging happiness and hope to the pub¥↑lic!
Beijing Haibu Pharmaceutic•$λ al Technology Co., Ltd. (referre σ↑σd to as "Haibu Pharmaceut ≥↔ ical") was established in ≤δ2005 and is a high-tech ent♦©₩✘erprise with "chemical drug rese€÷≥↔arch and development"™←β® as its core capability.♦∏≥ It has a research and develo♣™φ&pment center in Beijing, σ♥εa pilot verification cente® "∞r for raw materials £δand formulations, an∑∞d a GMP industrial production b &εase, mainly engaged in the technical development and transfδ←∑er of chemical drugs, MAH research and♠€ holding certificate' λσs, related applications for raw ¶•♣materials, and commerci≠↓₩al supply of pharmaceutical int₹<ermediates. and the application f♣☆or innovative and im↓™>proved drug research a¶δ¶®nd development, it has beenε♦£Ω awarded the title of "Top 20 Ph≥ ™armaceutical R&D Companies in Chin♠α♠a" for several consecutλ✔ ive years and recognized as "Beijing ™ <™Science and Technology Research and &γDevelopment Institution," >σ÷"National High-tech Enterpr↔×₩ise," and "Beijing Yizhuang ε£γ←Enterprise Innovation <♦Center."
Haibu Pharmaceutical has★♦ rich experience in the research and σ÷production transfer, registration, and ≤application of various dosage forms ≠™ such as chemical raw materials,σ¥÷ oral solids, liquid preparations, s&δterile injections, and externa&×l preparations. The ♣★R&D products cover multiple therap≤∞φeutic areas including anti-tumor, anti- ÷depression, anti-epilepsy, anti™♦•-anxiety, cardiovascular, dig±<εestive system, and respira♦®←₩tory system.
Beijing Hope Pharmaceutical Co., Ltd.
